← Open Payments lookup

DWIGHT SCHROEDER: Open Payments

NPI 1528047081 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,589 in 183 payments from 15 companies in 2025. Trend: 2023 $1,996 · 2024 $2,384 · 2025 $2,589

Food & beverage: $2,589
CompanyPaymentsAmount
ABBVIE INC.31$355
Otsuka America Pharmaceutical, Inc.17$340
Neurocrine BioSciences, Inc.36$307
Teva Pharmaceuticals USA, Inc.15$257
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)17$224
Alkermes, Inc.16$221
Supernus Pharmaceuticals, Inc.11$173
Vanda Pharmaceuticals Inc.8$166
E.R. Squibb & Sons, L.L.C.10$147
Lundbeck LLC6$124

Products named: REXULTI, VRAYLAR, INGREZZA, CAPLYTA, ARISTADA, AUSTEDO XR, Qelbree, FANAPT.

Industry payments across IA — which companies pay providers there.